Thirty Day Resource Utilization after Chimeric Antigen Receptor (CAR) T Cell Infusion for Hematologic Malignancies

被引：0

作者：

Shah, Gunjan L. ^{[1
]}

Park, Jae ^{[2
]}

Sauter, Craig S. ^{[1
]}

Duck, Elaine ^{[3
]}

Halton, Elizabeth ^{[4
]}

Batlevi, Connie W. ^{[5
]}

Palomba, M. Lia ^{[5
]}

Younes, Anas ^{[5
]}

Geyer, Mark B. ^{[2
]}

Smith, Eric ^{[6
]}

Mailankody, Sham ^{[6
]}

Mead, Elena ^{[7
]}

Santomasso, Bianca ^{[8
]}

Perales, Miguel-Angel ^{[9
]}

Sabbatini, Paul ^{[10
]}

Giralt, Sergio A. ^{[9
]}

Brentjens, Renier ^{[2
]}

Bach, Peter B. ^{[11
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, 1275 York Ave, New York, NY 10021 USA

[2] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA

[3] Mem Sloan Kettering Canc Ctr, Managed Care Outcomes Anal, 1275 York Ave, New York, NY 10021 USA

[4] Mem Sloan Kettering Canc Ctr, Cellular Therapeut Ctr, 1275 York Ave, New York, NY 10021 USA

[5] Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USA

[6] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, 1275 York Ave, New York, NY 10021 USA

[7] Mem Sloan Kettering Canc Ctr, Dept Anesthesiol & Crit Care Med, 1275 York Ave, New York, NY 10021 USA

[8] Mem Sloan Kettering Canc Ctr, Dept Neurol, Brain Tumor Serv, 1275 York Ave, New York, NY 10021 USA

[9] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[10] Mem Sloan Kettering Canc Ctr, Gynecol Med Oncol Serv, 1275 York Ave, New York, NY 10021 USA

[11] Mem Sloan Kettering Canc Ctr, Ctr Hlth Policy & Outcomes, 1275 York Ave, New York, NY 10021 USA

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2019年 / 25卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：2

共 50 条

[1] Resource Utilization Lady after Chimeric Antigen Receptor (CAR) T Cell Infusion for Hematologic Malignancies
Shah, Gunjan L.
Park, Jae H.
Sauter, Craig S.
Duck, Elaine
Halton, Elizabeth
Palomba, Maria Lia
Batlevi, Connie Lee
Younes, Anas
Geyer, Mark Blaine
Smith, Eric L.
Mailankody, Sham
Mead, Elena
Santomasso, Bianca
Perales, Miguel-Angel
Sabbatini, Paul
Giralt, Sergio
Brentjens, Renier J.
Bach, Peter
BLOOD, 2018, 132
[2] Infections after chimeric antigen receptor (CAR)-T-cell therapy for hematologic malignancies
Kampouri, Eleftheria
Little, Jessica S.
Rejeski, Kai
Manuel, Oriol
Hammond, Sarah P.
Hill, Joshua A.
TRANSPLANT INFECTIOUS DISEASE, 2023, 25
[3] Infections after chimeric antigen receptor (CAR)-T-cell therapy for hematologic malignancies
Kampouri, Eleftheria
Little, Jessica S.
Rejeski, Kai
Manuel, Oriol
Hammond, Sarah P.
Hill, Joshua A.
TRANSPLANT INFECTIOUS DISEASE, 2023, 25
[4] Chimeric antigen receptor T cell treatment in hematologic malignancies
Goker, Hakan
Malkan, Umit Yavuz
Demiroglu, Haluk
Buyukasik, Yahya
TRANSFUSION AND APHERESIS SCIENCE, 2016, 54 (01) : 35 - 40
[5] Radiotherapy for Relapse after Chimeric Antigen Receptor T Cell Therapy in Hematologic Malignancies
Hubbeling, H. G.
Silverman, E. A.
Tomas, A. Alarcon
Tringale, K. R.
Wijetunga, N. A.
Hajj, C.
Mailankody, S.
Batlevi, C. L.
Dahi, P. B.
Giralt, S. A.
Lin, R. J.
Park, J. H.
Scordo, M.
Sauter, C. S.
Shah, G. L.
Perales, M. A.
Palomba, M. L.
Shouval, R.
Yahalom, J.
Imber, B. S.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S56 - S57
[6] Chimeric Antigen Receptor (CAR) T-Cell Therapy in Hematologic Malignancies: Clinical Implications and Limitations
Bluem, Philipp
Kayser, Sabine
CANCERS, 2024, 16 (08)
[7] Cardiotoxicity Associated With Chimeric Antigen Receptor (CAR)-T Cell Therapy for Hematologic Malignancies: A Systematic Review
Hanna, Kerollos S.
Kaur, Harkirat
Alazzeh, Mohammad S.
Thandavaram, Abhay
Channar, Aneeta
Purohit, Ansh
Shrestha, Bijay
Patel, Deepkumar
Shah, Hriday
Mohammed, Lubna
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
[8] Chimeric Antigen Receptor T Cells in Hematologic Malignancies
Shank, Brandon R.
Do, Bryan
Sevin, Adrienne
Chen, Sheree E.
Neelapu, Sattva S.
Horowitz, Sandra B.
PHARMACOTHERAPY, 2017, 37 (03): : 334 - 345
[9] Chimeric Antigen Receptor T-cell Therapy to Target Hematologic Malignancies
Kenderian, Saad Sirop
Ruella, Marco
Gill, Saar
Kalos, Michael
CANCER RESEARCH, 2014, 74 (22) : 6383 - 6389
[10] Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance
Boyiadzis, Michael M.
Dhodapkar, Madhav V.
Brentjens, Renier J.
Kochenderfer, James N.
Neelapu, Sattva S.
Maus, Marcela V.
Porter, David L.
Maloney, David G.
Grupp, Stephan A.
Mackall, Crystal L.
June, Carl H.
Bishop, Michael R.
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6

← 1 2 3 4 5 →